Growth Metrics

Sarepta Therapeutics (SRPT) Free Cash Flow Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 60.84%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 88.70%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -15.72%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 66.37%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.98%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 137.65%
10 Sarepta Therapeutics 1.86 Bn 1.17 Bn 291.52 Mn 67.35%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 67.35%
Dec 31, 2025 136.48%
Sep 30, 2025 65.25%
Jun 30, 2025 1,713.64%
Mar 31, 2025 -128.43%
Dec 31, 2024 173.23%
Sep 30, 2024 25.22%
Jun 30, 2024 89.85%
Mar 31, 2024 -25.42%
Dec 31, 2023 26.57%
Sep 30, 2023 -97.25%
Jun 30, 2023 -84.66%
Mar 31, 2023 -105.09%
Dec 31, 2022 -218.27%
Sep 30, 2022 45.20%
Jun 30, 2022 34.03%
Mar 31, 2022 47.04%
Dec 31, 2021 84.48%
Sep 30, 2021 49.31%
Jun 30, 2021 9.25%
Mar 31, 2021 -132.57%
Dec 31, 2020 -12.20%
Sep 30, 2020 -242.82%
Jun 30, 2020 -32.49%
Mar 31, 2020 480.73%
Dec 31, 2019 -26.94%
Sep 30, 2019 42.39%
Jun 30, 2019 24.03%
Mar 31, 2019 -239.71%
Dec 31, 2018 -308.00%
Sep 30, 2018 -127.40%
Jun 30, 2018 -43.10%
Mar 31, 2018 23.29%
Dec 31, 2017 58.46%
Sep 30, 2017 4.54%
Jun 30, 2017 -101.40%
Mar 31, 2017 -0.80%
Dec 31, 2016 -160.06%
Sep 30, 2016 -29.49%
Jun 30, 2016 -49.83%
Mar 31, 2016 -40.97%
Dec 31, 2015 -13.18%
Sep 30, 2015 0.68%
Jun 30, 2015 33.74%
Mar 31, 2015 -30.63%
Dec 31, 2014 -55.12%
Sep 30, 2014 -125.35%
Jun 30, 2014 -254.19%
Mar 31, 2014 -123.91%
Dec 31, 2013 -157.47%
Sep 30, 2013 -172.91%
Jun 30, 2013 -113.69%
Mar 31, 2013 -65.62%
Dec 31, 2012 -22.30%
Sep 30, 2012 0.64%
Jun 30, 2012 -552.75%
Mar 31, 2012 12.00%
Dec 31, 2011 -179.78%
Sep 30, 2011 -155.47%